(ADPnews) - Oct 22, 2010 - German pharmaceutical group Merck KGaA (ETR:MRK) is expected to once again affirm its recovery phase at its upcoming presentation of financial results for the third quarter of 2010, posting strong year-on-year growth of sales and profits.
According to the analysts of DZ Bank, the core pharmaceutical business will turn out the growth driver, particularly with the …

Комментариев нет:
Отправить комментарий